三联采样对恶性胆道狭窄检测的影响:与原发性硬化性胆管炎患者的比较
这项单中心回顾性队列研究纳入2014年9月至2019年4月因胆道狭窄行ERCP并接受三联采样的204例患者(51.0%为恶性),评估刷检细胞学(BC)、荧光原位杂交(FISH)、经乳头活检(TPB)单独或联合的诊断性能。三联采样较BC+FISH和BC+TPB提高恶性胆道狭窄诊断敏感性,但在原发性硬化性胆管炎(PSC)患者中并不优于BC+FISH。
要点
- 三联采样诊断恶性胆道狭窄敏感性68.3%,高于BC+FISH的58.7%和BC+TPB的40.4%。
- PSC患者中BC+FISH检测恶性敏感性80%,三联采样85%,两者无显著差异(P=1)。
- 三联采样检测胆管癌敏感性79.7%,与胰腺癌62.5%相比无统计学显著差异(P=.1)。
核心结论
- 三联采样提高恶性胆道狭窄的诊断敏感性,检测胆管癌与胰腺癌的敏感性无显著差异;但在PSC患者中三联采样不优于BC+FISH。
研究设计与样本
- 单中心回顾性队列研究,纳入2014年9月至2019年4月因胆道狭窄行ERCP并接受三联采样的患者204例,其中恶性104例(51.0%)。
主要发现
- BC诊断恶性敏感性17.3%,双联(BC+FISH 58.7%;BC+TPB 40.4%)或三联采样(68.3%)均显著提高(所有比较P < .001)。
- 三联采样敏感性高于BC+FISH(P = .002)和BC+TPB(P < .001)。
- 三联采样检测胆管癌敏感性79.7%,胰腺癌62.5%,差异无统计学显著(P = .1)。
- 57例PSC患者中恶性20例,BC敏感性20%,加FISH提高至80%(P < .001),加TPB为35.0%(P = .25)。
- PSC患者中三联采样敏感性85%,BC+FISH为80%,差异无统计学显著(P = 1)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Malignant biliary strictures can be difficult to diagnose, with up to 20% considered indeterminate after initial tissue sampling. This study aimed to determine the performance characteristics of transpapillary biopsy sampling (TPB) and fluorescence in situ hybridization (FISH) in isolation or in combination with standard brush cytology (BC) in patients who received trimodality sampling for biliary strictures. METHODS: This single-center retrospective cohort study included patients with biliary strictures undergoing ERCP with trimodality sampling between September 2014 and April 2019. Performance characteristics for each diagnostic test alone and in combination were calculated. RESULTS: Two hundred four patients underwent trimodality biliary sampling, including 104 (51.0%) with malignancy. The diagnostic sensitivity for malignancy with BC (17.3%) significantly improved with dual modality (BC+FISH, 58.7%; BC+TPB, 40.4%) or trimodality sampling (68.3%; P < .001 for all comparisons). Trimodality sampling improved diagnostic sensitivity for malignancy compared with BC+FISH (P = .002) and BC+TPB (P < .001). There was no statistically significant difference in the sensitivity of trimodality sampling in detecting cholangiocarcinoma (79.7%) compared with pancreatic cancer (62.5%; P = .1). Among 57 patients with primary sclerosing cholangitis (PSC), the sensitivity of detecting biliary malignancy (n = 20) was 20% for BC and significantly improved with the addition of FISH (80%; P < .001) but not with TPB (35.0%; P = .25). Trimodality sampling did not further improve diagnostic sensitivity (85%) over BC+FISH (80%) for malignancy in the setting of PSC (P = 1). CONCLUSIONS: Trimodality sampling improves the diagnostic sensitivity for the detection of malignant biliary strictures with no significant difference in sensitivity for cholangiocarcinoma compared with pancreatic cancer. However, in patients with PSC, trimodality sampling was not superior to BC+FISH.
引用
- Baroud S, Sahakian AJ, Sawas T, et al. Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis. Gastrointest Endosc. 2021. PMID: 34871554. doi:10.1016/j.gie.2021.11.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。